Peptides for weight loss: what actually works, what's unproven, what's illegal
The only weight-loss peptides with FDA approval and large human trials are the GLP-1 drugs — semaglutide (~15% mean loss in STEP-1) and tirzepatide (~21% in SURMOUNT-1). Most products marketed online as 'weight-loss peptides' (BPC-157, ipamorelin, 'research-grade' retatrutide) have no human efficacy trials, no FDA oversight, and no sterility assurance.
2 min readUpdated
- 0
- peptide classes with FDA-approved weight-loss drugs (GLP-1, GLP-1/GIP)
- ~0% / ~21%
- mean loss: semaglutide (STEP-1) / tirzepatide (SURMOUNT-1)
- 0
- FDA-approved uses of BPC-157 or ipamorelin
- RUO
- 'research use only' peptides are illegal to sell for human use
Jump to section
"Peptides" is a chemistry word, not a product category
A peptide is just a short chain of amino acids. Insulin is a peptide. So are semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro). When influencers talk about 'peptides for weight loss', they lump two very different things together: prescription drugs that happen to be peptides and passed FDA review, and unapproved compounds sold by online 'peptide shops' with no human trials behind them.
That distinction — approved drug vs unregulated chemical — matters more than any mechanism claim, because it decides whether anyone verified what is actually in the vial.
The peptides with real evidence: GLP-1s
Semaglutide 2.4 mg produced ~14.9% mean body-weight reduction at 68 weeks in the STEP-1 trial (n=1,961). Tirzepatide 15 mg produced ~20.9% at 72 weeks in SURMOUNT-1 (n=2,539). Both are FDA-approved, manufactured under GMP, and prescribed with clinical monitoring. These are the weight-loss peptides that work, full stop.
If you're comparing legitimate access paths — telehealth programs, manufacturer direct-pay, insurance — see our GLP-1 program comparison and cost tools.
The gray market: 'research use only' vials
Online peptide shops sell vials labeled 'research use only' (RUO) — including copies of retatrutide (an investigational drug still in Phase 3, with no published FDA action date) and compounds like BPC-157. RUO labeling is a legal fig leaf: selling these for human injection is illegal, and the FDA has issued warning letters to sellers marketing unapproved GLP-1 products to consumers.
The practical risks are concrete: no sterility assurance (these are injected), no dose verification, and no purity testing. FDA has also flagged BPC-157 among substances raising safety concerns for compounded use. Unlike a pharmacy prescription, there is no batch recall system when something goes wrong.
How to tell the difference in 30 seconds
Three questions: (1) Does it require a prescription from a licensed clinician? (2) Is it dispensed by a state-licensed pharmacy? (3) Does the substance have an FDA-approved label you can read? If any answer is no, you are buying an unregulated chemical, not a medication.
Popular names sorted honestly: semaglutide and tirzepatide — approved, evidence-backed. Liraglutide (Saxenda) — approved, older, less effective. Retatrutide — promising Phase 3 data but not approved; anything sold as retatrutide today is gray-market. BPC-157, ipamorelin, CJC-1295, 'tesamorelin for fat loss' — no FDA-approved weight-loss use, no large human weight-loss trials.
Sources
Primary sources cited above. FDA labeling, peer-reviewed trials, and specialty-society guidelines only.
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) · New England Journal of Medicine, 2021 · PMID 33567185
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) · New England Journal of Medicine, 2022 · PMID 35658024
- Human drug compounding: FDA concerns and enforcement · U.S. Food and Drug Administration, 2025
- FDA warning letters database (unapproved GLP-1 and peptide sellers) · U.S. Food and Drug Administration, 2025
People also ask
What is the best peptide for weight loss?
Tirzepatide (Zepbound) has the strongest trial results of any weight-loss peptide — about 21% mean body-weight reduction at 72 weeks in SURMOUNT-1, and it beat semaglutide head-to-head in SURMOUNT-5. Semaglutide (Wegovy) is the second-best-evidenced option. Both are FDA-approved prescription drugs; no unapproved 'research peptide' has comparable human evidence.
Are peptides from online peptide shops safe?
No safety system stands behind them. 'Research use only' vials are not made under pharmaceutical GMP, are not tested for sterility or dose accuracy by any regulator, and are illegal to sell for human use. FDA has warned sellers marketing unapproved GLP-1 products. If you want a weight-loss peptide, the safe path is a prescription filled by a licensed pharmacy.
Is BPC-157 approved for anything?
No. BPC-157 has no FDA-approved use for any condition, and FDA has flagged it among substances raising safety concerns when compounded. Evidence in humans is limited to small studies; the popular claims are extrapolated from animal research.
Can I buy retatrutide now?
Not legally as a medication. Retatrutide is investigational — Phase 3 trials are ongoing and no FDA action date has been published. Vials sold online as retatrutide are gray-market products with no verification of contents. If the trial data holds up, it would reach pharmacies through the normal approval path.
Related reads
CagriSema: the amylin + GLP-1 combo and what REDEFINE actually showed (2026)
CagriSema pairs semaglutide with cagrilintide, an amylin analog — a different mechanism from tirzepatide or retatrutide. Its phase 3 REDEFINE 1 trial showed about 20% average weight loss at 68 weeks. Here's the evidence, how it differs, and its status.
Zepbound for sleep apnea: what the FDA approval and SURMOUNT-OSA actually showed (2026)
In December 2024 tirzepatide (Zepbound) became the first drug FDA-approved for obstructive sleep apnea. Here is what the SURMOUNT-OSA trials measured, how much it reduced apnea events, and who the approval is — and isn't — for.
Ozempic before and after in 2026: realistic results month-by-month
Ozempic results vary widely — STEP-1 trial showed mean 14.9% weight loss for semaglutide at the higher Wegovy dose, but on Ozempic's 2.0mg max dose for T2D, expect 6-10% over 6-9 months. Visual changes follow scale weight closely. Here's what realistic before/after looks like month-by-month and why social media expectations can be misleading.